Dimethylformamide → HCID 16063558, compound
Reaction equation
[C:1]12([C:11]3[C:12](=[O:17])[NH:13][NH:14][C:15]=3[CH3:16])[CH2:10][CH:5]3[CH2:6][CH:7]([CH2:9][CH:3]([CH2:4]3)[CH2:2]1)[CH2:8]2.Br[CH2:19][CH2:20][CH2:21]Br.CN(C=O)C.C(=O)([O-])[O-].[K+].[K+]>CCOC(C)=O.C(=O)(O)[O-].[Na+]>[C:1]12([C:11]3[C:12](=[O:17])[N:13]4[CH2:19][CH2:20][CH2:21][N:14]4[C:15]=3[CH3:16])[CH2:2][CH:3]3[CH2:9][CH:7]([CH2:6][CH:5]([CH2:4]3)[CH2:10]1)[CH2:8]2Participants
Conditions
- Temperature
- 100 °C
Procedure
Into a sealable pressure vessel was placed 4-adamantan-1-yl-5-methyl-1,2-dihydro-pyrazol-3-one (3.5 g) (as described in example 48) along with 1,3-dibromopropane (6.1 g) and DMF (40 mL) and one equivalent of solid potassium carbonate. The reaction vessel was sealed and the solution was heated to 100° C. for 20 hours. The reaction was then allowed to cool and diluted with EtOAc and saturated sodium bicarbonate solution. The phases were separated and the aqueous phase was extracted with further EtOAc. The combined organic phases were washed with brine, dried over sodium sulfate, filtered and evaporated in vacuo. The obtained residue was purified via ISCO Combiflash chromatography (over silica column, eluting with EtOAc/heptane) to afford 2-adamantan-1-yl-3-methyl-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-one (0.821 g) as a white solid. MS (ESI+): 273.0 [M+H]+).
Workup
- customInto a sealable pressure vessel was placed
- customThe reaction vessel was sealed
- temperatureto cool
- customThe phases were separated
- extractionthe aqueous phase was extracted with further EtOAc
- washThe combined organic phases were washed with brine
- dry with materialdried over sodium sulfate
- filtrationfiltered
- customevaporated in vacuo
- customThe obtained residue was purified via ISCO Combiflash chromatography (over silica column, eluting with EtOAc/heptane)
Sources & evidence
- ORD record
- ord-f336daa3ce454f5387cd0354dd1f9191
- Source dataset
- uspto-grants-2010_01
- Patent number
- US07652057B2
Reaction notes
Loading…